Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells (Cancer Immunology, Immunotherapy, (2021), 70, 5, (1305-1321), 10.1007/s00262-020-02749-8)

J. M.R. Van der Meer, R. J.A. Maas, K. Guldevall, K. Klarenaar, P. K.J.D. De Jonge, J. S. Hoogstad-van Evert, A. B. van der Waart, J. Cany, J. T. Safrit, J. H. Lee, E. Wagena, P. Friedl, B. Önfelt, L. F. Massuger, N. P.M. Schaap, J. H. Jansen, W. Hobo, H. Dolstra

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells (Cancer Immunology, Immunotherapy, (2021), 70, 5, (1305-1321), 10.1007/s00262-020-02749-8)'. Together they form a unique fingerprint.

Medicine & Life Sciences